Reata stock news
Webb21 feb. 2024 · Reata Pharmaceuticals Inc (RETA) stock is trading at $38.48 as of 12:34 PM on Tuesday, Feb 21, a decline of -$10.35, or -21.2% from the previous closing price of $48.83. The stock has traded between $37.82 and $48.54 so far today. Volume today is … WebbFör 1 dag sedan · On 13 April 2024, the Board of Directors of Targovax ASA approved theCompany'sAnnual Report, including the financial statements for 2024, which will beprocessed at the Company's annual general meeting on 22 May 2024. Targovax ASAalso publishes today its annual financial statements in the European S…
Reata stock news
Did you know?
Webb28 mars 2024 · Cantor Fitzgerald currently has an overweight rating on the stock. Reata Pharmaceuticals traded as high as $92.75 and last traded at $92.07. Approximately 260,375 shares traded hands during ... Webb11 apr. 2024 · 6 analysts have issued twelve-month price objectives for Reata Pharmaceuticals' stock. Their RETA share price forecasts range from $67.00 to $138.00. …
Webb6 apr. 2024 · Fintel reports that on April 13, 2024, Stifel maintained coverage of Reata Pharmaceuticals (NASDAQ:RETA) with a Buy recommendation. Analyst Price Forecast Suggests 20.79% Upside As of April 6,... Webb13 apr. 2024 · Reata Pharmaceuticals Inc (RETA) stock is trading at $96.63 as of 3:23 PM on Thursday, Apr 13, a rise of $0.14, or 0.15% from the previous closing price of $96.49. …
Webb6 apr. 2024 · Reata Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing therapies. The Company concentrates on small-molecule therapeutics with mechanisms of action for the treatment of severe, life-threatening diseases. Webb2 mars 2024 · Reata Pharmaceuticals RETA stock skyrocketed almost 200% on Wednesday, a day after the FDA approved its drug Skyclarys, or omaveloxolone, across a …
Webb市场头条新闻、重点公司财报、实时市场数据和深度分析文章。
Webb14 apr. 2024 · Reata Pharmaceuticals Stock Performance RETA opened at $96.01 on Thursday. Reata Pharmaceuticals has a 52 week low of $18.47 and a 52 week high of $98.89. The firm has a market capitalization... safe return program alzheimer\u0027s associationWebbOn average, Wall Street analysts predict that Reata Pharmaceuticals 's share price could reach $115.50 by Mar 27, 2024. The average Reata Pharmaceuticals stock price prediction forecasts a potential upside of 22.9% from the current RETA share price of $93.98. What is RETA's forecast return on assets (ROA) for 2024-2026? safe rewards programWebbFör 1 dag sedan · Reata Pharma has recently broken out of its tight trading range after gapping into the $80.00 - $96.00 area due to its FDA approval of ... More Stock Market News from Barchart. safe return to in person instruction faqsWebb13 mars 2024 · Reata Pharmaceuticals ’ RETA shares have more than doubled in 2024. The main reason for the surge is the approval of its Skyclarys or omaveloxolone, across a … safer families birmingham referralWebbBreaking Reata Pharma stock halted after hours at $100.59 Oct. 14, 2024 at 4:03 p.m. ET by Wallace Witkowski Other News Press Releases Entera Bio Ltd. (ENTX) Reports Q4 … safer express busWebb13 apr. 2024 · Shares of RETA stock opened at $96.49 on Thursday. Reata Pharmaceuticals has a 1-year low of $18.47 and a 1-year high of $98.52. The company has a market capitalization of $3.54 billion, a price-to-earnings ratio of -11.27 and a beta of 1.52. The stock's fifty day simple moving average is $72.33 and its 200-day simple … safe reverse image searchWebbStock Price Forecast The 10 analysts offering 12-month price forecasts for Reata Pharmaceuticals Inc have a median target of 105.00, with a high estimate of 198.00 and a low estimate of 75.00.... safer families cardiff